Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs heparin vs enoxaparin for thromboprophylaxis in gynecologic oncology surgery
IRCT20151020024625N19Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in venous thromboembolism (VTE) and pulmonary embolism (PE) comparing Rivaroxaban, Heparin and Enoxaparin (3 arms). Started May 2024; status: completed.
02
Drugs
rivaroxabanheparinenoxaparin
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)
Beyond the preview
Go deeper on IRCT20151020024625N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151020024625N19.